Are you over 18 and want to see adult content?
More Annotations
![A complete backup of hashmiphotos.com](https://www.archivebay.com/archive/710d9b51-dc22-4d25-aff1-9e20ff577afa.png)
A complete backup of hashmiphotos.com
Are you over 18 and want to see adult content?
![A complete backup of manualidadesenaoso.blogspot.com](https://www.archivebay.com/archive/67a225fd-3cd7-4854-b1c2-62de0e0f1b91.png)
A complete backup of manualidadesenaoso.blogspot.com
Are you over 18 and want to see adult content?
![A complete backup of casablancachile.cl](https://www.archivebay.com/archive/1c5b5fda-6d1e-426d-9177-4e899133baba.png)
A complete backup of casablancachile.cl
Are you over 18 and want to see adult content?
![A complete backup of endlesssorcererushiromiya.tumblr.com](https://www.archivebay.com/archive/abbdfe04-b78e-470e-a5e3-dc762a55e9e1.png)
A complete backup of endlesssorcererushiromiya.tumblr.com
Are you over 18 and want to see adult content?
![A complete backup of visiterlafrique.com](https://www.archivebay.com/archive/10423098-f93c-4d4c-a7e0-8947b5be5f29.png)
A complete backup of visiterlafrique.com
Are you over 18 and want to see adult content?
![A complete backup of trinidadforsale.com](https://www.archivebay.com/archive/c3191f1e-fd03-44b1-9ed8-1fe868bb911a.png)
A complete backup of trinidadforsale.com
Are you over 18 and want to see adult content?
![A complete backup of affordablecebu.com](https://www.archivebay.com/archive/f7c8fe22-8a3e-4009-8aeb-e40e331e7506.png)
A complete backup of affordablecebu.com
Are you over 18 and want to see adult content?
![A complete backup of kellyservices.com](https://www.archivebay.com/archive/57c21237-ee35-4c6a-ba98-09311cd3c92e.png)
A complete backup of kellyservices.com
Are you over 18 and want to see adult content?
Favourite Annotations
![A complete backup of www.espn.com/soccer/report?gameId=567906](https://www.archivebay.com/archive2/836719c2-c361-4b95-9ea4-044331c473a0.png)
A complete backup of www.espn.com/soccer/report?gameId=567906
Are you over 18 and want to see adult content?
![A complete backup of stirimondene.fanatik.ro/maia-morgenstern-visa-in-copilarie-sa-devina-balerina-actrita-a-avut-parte-de-o-edu](https://www.archivebay.com/archive2/00b347f6-f9b5-448f-9bf8-4c9167f381f3.png)
A complete backup of stirimondene.fanatik.ro/maia-morgenstern-visa-in-copilarie-sa-devina-balerina-actrita-a-avut-parte-de-o-edu
Are you over 18 and want to see adult content?
![A complete backup of www.radiomaryja.pl/informacje/zona-i-syn-z-stonogi-zostali-zatrzymani-ws-przywlaszczenia-prawie-mln-zl-na-s](https://www.archivebay.com/archive2/bdc8296e-cdcc-48dc-9102-96fff4af714e.png)
A complete backup of www.radiomaryja.pl/informacje/zona-i-syn-z-stonogi-zostali-zatrzymani-ws-przywlaszczenia-prawie-mln-zl-na-s
Are you over 18 and want to see adult content?
![A complete backup of www.naidunia.com/national-pulwama-attack-anniversary-nation-remembers-martyrs-of-pulwama-attack-twitter-flo](https://www.archivebay.com/archive2/af2ed87a-7ff5-465b-a323-ed1329e62ae3.png)
A complete backup of www.naidunia.com/national-pulwama-attack-anniversary-nation-remembers-martyrs-of-pulwama-attack-twitter-flo
Are you over 18 and want to see adult content?
Text
PROQUAD - MERCK
ProQuad® (Measles, Mumps, Rubella and Varicella Virus Vaccine Live) Page 6 of 42 Vaccine recipients should attempt to avoid, whenever possible, close association with high-risk individuals susceptible to varicella for up to 6 weeks following vaccination. PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION … NEXPLANON® (etonogestrel extended release subdermal implant) Page 1 of 56. PRODUCT MONOGRAPH . INCLUDING PATIENT MEDICATION INFORMATION. NEXPLANON® Etonogestrel extended release subdermal implant . Extended release implant, 68 mg per implant (to deliver up to 70 mcg etonogestrel per day),PRODUCT MONOGRAPH
VARIVAX® III (varicella virus vaccine, live, attenuated ) Page 6 of 24 Nursing Women: It is not known whether varicella vaccine virus is secreted in human milk. Therefore, because some viruses are secreted in human milk, caution should be exercised if VARIVAX® III is administered to a nursing woman.PRHADLIMA PUSHTOUCH
PrHADLIMA® PrHADLIMA® PushTouch® Page 1 of 148. PRODUCT MONOGRAPH . INCLUDING PATIENT MEDICATION INFORMATION . PrHADLIMA®. adalimumab injection . 40 mg in 0.8 mL sterile solution (50 mg/mL), pre-filled syringe for subcutaneous injectionPRODUCT MONOGRAPH
ESTROGEL® (17ß-estradiol, as estradiol hemihydrate) Product Monograph Page 5 of 39 for short-interval follow-up, a suspicious abnormality, or highly suggestive of malignancy) was significantly higher in the estrogen plus progestin group versus the placebo group.PRODUCT MONOGRAPH
GARDASIL®9 Page
4 of 45 INDICATIONS AND CLINICAL USE Girls and Women GARDASIL®9 is a vaccine indicated in girls and women 9 through 45 years of age for the prevention of infection caused by the Human Papillomavirus (HPV) types6,
PRODUCT MONOGRAPH
Cotazym® (Pancrelipase) Page 1 of 14 PRODUCT MONOGRAPH COTAZYM® Pancrelipase Preparations Cotazym® Capsules: 10,000 USP units (Lipase activity) / 40,000 USPKEYTRUDA® - MERCK
KEYTRUDA® (pembrolizumab) Page 4 of 161 RECENT MAJOR LABEL CHANGES 1 Indications 03/2021 4 Dosage and Administration, 4.2 Recommended Dose and Dosage Adjustment 04/2021 7 Warnings and Precautions 02/2021 HOME | MERCK CANADACONTACT USPRESCRIPTION PRODUCTSAPPLY NOWWORLDWIDEABOUT USNEWSROOM HADLIMA ® (adalimumab injection) Now Available for the Treatment of Rheumatoid Arthritis, Polyarticular Juvenile Idiopathic Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Adult Crohn’s Disease, Ulcerative Colitis, Hidradenitis Suppurativa, Plaque Psoriasis, Adult and Pediatric Uveitiss and men 9 - 45 years of age. Learn more. [PRODUCT MONOGRAPH TEMPLATE M-M-R® II (measles, mumps and rubella virus vaccine, live, attenuated, Merck Std.) Page 1 of 29. PRODUCT MONOGRAPH. M-M-R® II (measles, mumps and rubella virus vaccine, live, attenuated, Merck Std.) Single-dose vials . Lyophilized powder for injectionPROQUAD - MERCK
ProQuad® (Measles, Mumps, Rubella and Varicella Virus Vaccine Live) Page 6 of 42 Vaccine recipients should attempt to avoid, whenever possible, close association with high-risk individuals susceptible to varicella for up to 6 weeks following vaccination. PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION … NEXPLANON® (etonogestrel extended release subdermal implant) Page 1 of 56. PRODUCT MONOGRAPH . INCLUDING PATIENT MEDICATION INFORMATION. NEXPLANON® Etonogestrel extended release subdermal implant . Extended release implant, 68 mg per implant (to deliver up to 70 mcg etonogestrel per day),PRODUCT MONOGRAPH
VARIVAX® III (varicella virus vaccine, live, attenuated ) Page 6 of 24 Nursing Women: It is not known whether varicella vaccine virus is secreted in human milk. Therefore, because some viruses are secreted in human milk, caution should be exercised if VARIVAX® III is administered to a nursing woman.PRHADLIMA PUSHTOUCH
PrHADLIMA® PrHADLIMA® PushTouch® Page 1 of 148. PRODUCT MONOGRAPH . INCLUDING PATIENT MEDICATION INFORMATION . PrHADLIMA®. adalimumab injection . 40 mg in 0.8 mL sterile solution (50 mg/mL), pre-filled syringe for subcutaneous injectionPRODUCT MONOGRAPH
ESTROGEL® (17ß-estradiol, as estradiol hemihydrate) Product Monograph Page 5 of 39 for short-interval follow-up, a suspicious abnormality, or highly suggestive of malignancy) was significantly higher in the estrogen plus progestin group versus the placebo group.PRODUCT MONOGRAPH
GARDASIL®9 Page
4 of 45 INDICATIONS AND CLINICAL USE Girls and Women GARDASIL®9 is a vaccine indicated in girls and women 9 through 45 years of age for the prevention of infection caused by the Human Papillomavirus (HPV) types6,
PRODUCT MONOGRAPH
Cotazym® (Pancrelipase) Page 1 of 14 PRODUCT MONOGRAPH COTAZYM® Pancrelipase Preparations Cotazym® Capsules: 10,000 USP units (Lipase activity) / 40,000 USPKEYTRUDA® - MERCK
KEYTRUDA® (pembrolizumab) Page 4 of 161 RECENT MAJOR LABEL CHANGES 1 Indications 03/2021 4 Dosage and Administration, 4.2 Recommended Dose and Dosage Adjustment 04/2021 7 Warnings and Precautions 02/2021 CONTACT US | MERCK CANADA To get in touch with a Merck Canada employee, contact our Canadian head office. Here is how you can reach us: Merck Canada Inc. 16750 Trans-Canada Highway. Kirkland, Quebec H9H 4M7. Phone: 514-428-7920. Toll free phone: 1-800-361-7031. For more information about charitable contributions/donations support or to submit a request, please clickhere.
CAREERS | MERCK CANADA Apply Now. Learn more about our work, search for jobs, and gain the information you need to decide if Merck is a match for you. We'll show you where your expertise can add value and how to apply for the positions that interest you. In the end, we hope you discover morePRODUCT MONOGRAPH
ESTROGEL® (17ß-estradiol, as estradiol hemihydrate) Product Monograph Page 5 of 39 for short-interval follow-up, a suspicious abnormality, or highly suggestive of malignancy) was significantly higher in the estrogen plus progestin group versus the placebo group.PRODUCT MONOGRAPH
PRODUCT MONOGRAPH . PUREGON® (follitropin beta) Solution for injection in cartridges (recFSH) 300 IU/0.36 mL, 600 IU/0.72 mL or . 900 IU/1.08 mL solution for injectionPRODUCT MONOGRAPH
Page 1 of 34 PRODUCT MONOGRAPH PROMETRIUM® Progesterone capsules 100 mg Progestin Merck Canada Inc. 16750 route Transcanadienne Kirkland QCCanada H9H 4M7
PRODUCT MONOGRAPH
CANCIDAS® (caspofungin acetate) Page 6 of 50 Nursing Women: It is not known whether caspofungin is excreted in human milk. Caspofungin has been found in the milk of lactating laboratory animals. Women receiving CANCIDAS® should not breast-feed. Pediatrics (≤ 17 years of age): The safety and effectiveness of CANCIDAS® in pediatric patients aged 12 months to 17 years of age are supported byPRODUCT MONOGRAPH
FOSAMAX® (alendronate sodium) Page 1 of 42 PRODUCT MONOGRAPH FOSAMAX alendronate sodium tablets 70 mg alendronate Bone Metabolism Regulator Merck Canada Inc. Date of Revision: 16750 route Transcanadienne May 26, 2017 Kirkland, Quebec H9H 4M7KEYTRUDA - MERCK
KEYTRUDA® (pembrolizumab) Page 3 of 87 This product has been approved under the Notice of Compliance with Conditions (NOC/c) policy for one or all of its indicated uses. What is a Notice of Compliance withConditions (NOC/c)?
GARDASIL PRODUCT MONOGRAPH GARDASIL® Page 4 of 62 GARDASIL® is indicated in girls and women 9- through 26 years of age for the prevention of: - Anal cancer caused by HPV types 16 and 18 - Anal intraepithelial neoplasia (AIN) grades 1, 2, and 3 caused by HPV types 6, 11, 16, (ADALIMUMAB INJECTION) NOW AVAILABLE FOR THE TREATMENT OF same rigorous standards used to ensure the quality, efficacy and safety as in any other biologic drug.19 Biosimilars provide patients more treatment options to help manage their disease and symptoms. Clinical efficacy and safety studies have been conducted in patients with RA to demonstrate HOME | MERCK CANADACONTACT USPRESCRIPTION PRODUCTSAPPLY NOWWORLDWIDEABOUT USNEWSROOM HADLIMA ® (adalimumab injection) Now Available for the Treatment of Rheumatoid Arthritis, Polyarticular Juvenile Idiopathic Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Adult Crohn’s Disease, Ulcerative Colitis, Hidradenitis Suppurativa, Plaque Psoriasis, Adult and Pediatric Uveitiss and men 9 - 45 years of age. Learn more. [PRODUCT MONOGRAPH TEMPLATE M-M-R® II (measles, mumps and rubella virus vaccine, live, attenuated, Merck Std.) Page 1 of 29. PRODUCT MONOGRAPH. M-M-R® II (measles, mumps and rubella virus vaccine, live, attenuated, Merck Std.) Single-dose vials . Lyophilized powder for injectionPROQUAD - MERCK
ProQuad® (Measles, Mumps, Rubella and Varicella Virus Vaccine Live) Page 6 of 42 Vaccine recipients should attempt to avoid, whenever possible, close association with high-risk individuals susceptible to varicella for up to 6 weeks following vaccination. PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION … NEXPLANON® (etonogestrel extended release subdermal implant) Page 1 of 56. PRODUCT MONOGRAPH . INCLUDING PATIENT MEDICATION INFORMATION. NEXPLANON® Etonogestrel extended release subdermal implant . Extended release implant, 68 mg per implant (to deliver up to 70 mcg etonogestrel per day),PRODUCT MONOGRAPH
VARIVAX® III (varicella virus vaccine, live, attenuated ) Page 6 of 24 Nursing Women: It is not known whether varicella vaccine virus is secreted in human milk. Therefore, because some viruses are secreted in human milk, caution should be exercised if VARIVAX® III is administered to a nursing woman.PRHADLIMA PUSHTOUCH
PrHADLIMA® PrHADLIMA® PushTouch® Page 1 of 148. PRODUCT MONOGRAPH . INCLUDING PATIENT MEDICATION INFORMATION . PrHADLIMA®. adalimumab injection . 40 mg in 0.8 mL sterile solution (50 mg/mL), pre-filled syringe for subcutaneous injectionPRODUCT MONOGRAPH
ESTROGEL® (17ß-estradiol, as estradiol hemihydrate) Product Monograph Page 5 of 39 for short-interval follow-up, a suspicious abnormality, or highly suggestive of malignancy) was significantly higher in the estrogen plus progestin group versus the placebo group.PRODUCT MONOGRAPH
GARDASIL®9 Page
4 of 45 INDICATIONS AND CLINICAL USE Girls and Women GARDASIL®9 is a vaccine indicated in girls and women 9 through 45 years of age for the prevention of infection caused by the Human Papillomavirus (HPV) types6,
PRODUCT MONOGRAPH
Cotazym® (Pancrelipase) Page 1 of 14 PRODUCT MONOGRAPH COTAZYM® Pancrelipase Preparations Cotazym® Capsules: 10,000 USP units (Lipase activity) / 40,000 USPKEYTRUDA® - MERCK
KEYTRUDA® (pembrolizumab) Page 4 of 161 RECENT MAJOR LABEL CHANGES 1 Indications 03/2021 4 Dosage and Administration, 4.2 Recommended Dose and Dosage Adjustment 04/2021 7 Warnings and Precautions 02/2021 HOME | MERCK CANADACONTACT USPRESCRIPTION PRODUCTSAPPLY NOWWORLDWIDEABOUT USNEWSROOM HADLIMA ® (adalimumab injection) Now Available for the Treatment of Rheumatoid Arthritis, Polyarticular Juvenile Idiopathic Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Adult Crohn’s Disease, Ulcerative Colitis, Hidradenitis Suppurativa, Plaque Psoriasis, Adult and Pediatric Uveitiss and men 9 - 45 years of age. Learn more. [PRODUCT MONOGRAPH TEMPLATE M-M-R® II (measles, mumps and rubella virus vaccine, live, attenuated, Merck Std.) Page 1 of 29. PRODUCT MONOGRAPH. M-M-R® II (measles, mumps and rubella virus vaccine, live, attenuated, Merck Std.) Single-dose vials . Lyophilized powder for injectionPROQUAD - MERCK
ProQuad® (Measles, Mumps, Rubella and Varicella Virus Vaccine Live) Page 6 of 42 Vaccine recipients should attempt to avoid, whenever possible, close association with high-risk individuals susceptible to varicella for up to 6 weeks following vaccination. PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION … NEXPLANON® (etonogestrel extended release subdermal implant) Page 1 of 56. PRODUCT MONOGRAPH . INCLUDING PATIENT MEDICATION INFORMATION. NEXPLANON® Etonogestrel extended release subdermal implant . Extended release implant, 68 mg per implant (to deliver up to 70 mcg etonogestrel per day),PRODUCT MONOGRAPH
VARIVAX® III (varicella virus vaccine, live, attenuated ) Page 6 of 24 Nursing Women: It is not known whether varicella vaccine virus is secreted in human milk. Therefore, because some viruses are secreted in human milk, caution should be exercised if VARIVAX® III is administered to a nursing woman.PRHADLIMA PUSHTOUCH
PrHADLIMA® PrHADLIMA® PushTouch® Page 1 of 148. PRODUCT MONOGRAPH . INCLUDING PATIENT MEDICATION INFORMATION . PrHADLIMA®. adalimumab injection . 40 mg in 0.8 mL sterile solution (50 mg/mL), pre-filled syringe for subcutaneous injectionPRODUCT MONOGRAPH
ESTROGEL® (17ß-estradiol, as estradiol hemihydrate) Product Monograph Page 5 of 39 for short-interval follow-up, a suspicious abnormality, or highly suggestive of malignancy) was significantly higher in the estrogen plus progestin group versus the placebo group.PRODUCT MONOGRAPH
GARDASIL®9 Page
4 of 45 INDICATIONS AND CLINICAL USE Girls and Women GARDASIL®9 is a vaccine indicated in girls and women 9 through 45 years of age for the prevention of infection caused by the Human Papillomavirus (HPV) types6,
PRODUCT MONOGRAPH
Cotazym® (Pancrelipase) Page 1 of 14 PRODUCT MONOGRAPH COTAZYM® Pancrelipase Preparations Cotazym® Capsules: 10,000 USP units (Lipase activity) / 40,000 USPKEYTRUDA® - MERCK
KEYTRUDA® (pembrolizumab) Page 4 of 161 RECENT MAJOR LABEL CHANGES 1 Indications 03/2021 4 Dosage and Administration, 4.2 Recommended Dose and Dosage Adjustment 04/2021 7 Warnings and Precautions 02/2021 CONTACT US | MERCK CANADA To get in touch with a Merck Canada employee, contact our Canadian head office. Here is how you can reach us: Merck Canada Inc. 16750 Trans-Canada Highway. Kirkland, Quebec H9H 4M7. Phone: 514-428-7920. Toll free phone: 1-800-361-7031. For more information about charitable contributions/donations support or to submit a request, please clickhere.
CAREERS | MERCK CANADA Apply Now. Learn more about our work, search for jobs, and gain the information you need to decide if Merck is a match for you. We'll show you where your expertise can add value and how to apply for the positions that interest you. In the end, we hope you discover morePRODUCT MONOGRAPH
ESTROGEL® (17ß-estradiol, as estradiol hemihydrate) Product Monograph Page 5 of 39 for short-interval follow-up, a suspicious abnormality, or highly suggestive of malignancy) was significantly higher in the estrogen plus progestin group versus the placebo group.PRODUCT MONOGRAPH
PRODUCT MONOGRAPH . PUREGON® (follitropin beta) Solution for injection in cartridges (recFSH) 300 IU/0.36 mL, 600 IU/0.72 mL or . 900 IU/1.08 mL solution for injectionPRODUCT MONOGRAPH
Page 1 of 34 PRODUCT MONOGRAPH PROMETRIUM® Progesterone capsules 100 mg Progestin Merck Canada Inc. 16750 route Transcanadienne Kirkland QCCanada H9H 4M7
PRODUCT MONOGRAPH
CANCIDAS® (caspofungin acetate) Page 6 of 50 Nursing Women: It is not known whether caspofungin is excreted in human milk. Caspofungin has been found in the milk of lactating laboratory animals. Women receiving CANCIDAS® should not breast-feed. Pediatrics (≤ 17 years of age): The safety and effectiveness of CANCIDAS® in pediatric patients aged 12 months to 17 years of age are supported byPRODUCT MONOGRAPH
FOSAMAX® (alendronate sodium) Page 1 of 42 PRODUCT MONOGRAPH FOSAMAX alendronate sodium tablets 70 mg alendronate Bone Metabolism Regulator Merck Canada Inc. Date of Revision: 16750 route Transcanadienne May 26, 2017 Kirkland, Quebec H9H 4M7KEYTRUDA - MERCK
KEYTRUDA® (pembrolizumab) Page 3 of 87 This product has been approved under the Notice of Compliance with Conditions (NOC/c) policy for one or all of its indicated uses. What is a Notice of Compliance withConditions (NOC/c)?
GARDASIL PRODUCT MONOGRAPH GARDASIL® Page 4 of 62 GARDASIL® is indicated in girls and women 9- through 26 years of age for the prevention of: - Anal cancer caused by HPV types 16 and 18 - Anal intraepithelial neoplasia (AIN) grades 1, 2, and 3 caused by HPV types 6, 11, 16, (ADALIMUMAB INJECTION) NOW AVAILABLE FOR THE TREATMENT OF same rigorous standards used to ensure the quality, efficacy and safety as in any other biologic drug.19 Biosimilars provide patients more treatment options to help manage their disease and symptoms. Clinical efficacy and safety studies have been conducted in patients with RA to demonstrate HOME | MERCK CANADACONTACT USPRESCRIPTION PRODUCTSAPPLY NOWWORLDWIDEABOUT USNEWSROOM HADLIMA ® (adalimumab injection) Now Available for the Treatment of Rheumatoid Arthritis, Polyarticular Juvenile Idiopathic Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Adult Crohn’s Disease, Ulcerative Colitis, Hidradenitis Suppurativa, Plaque Psoriasis, Adult and Pediatric Uveitiss and men 9 - 45 years of age. Learn more. [PRODUCT MONOGRAPH TEMPLATE M-M-R® II (measles, mumps and rubella virus vaccine, live, attenuated, Merck Std.) Page 1 of 29. PRODUCT MONOGRAPH. M-M-R® II (measles, mumps and rubella virus vaccine, live, attenuated, Merck Std.) Single-dose vials . Lyophilized powder for injectionPROQUAD - MERCK
ProQuad® (Measles, Mumps, Rubella and Varicella Virus Vaccine Live) Page 6 of 42 Vaccine recipients should attempt to avoid, whenever possible, close association with high-risk individuals susceptible to varicella for up to 6 weeks following vaccination. PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION … NEXPLANON® (etonogestrel extended release subdermal implant) Page 1 of 56. PRODUCT MONOGRAPH . INCLUDING PATIENT MEDICATION INFORMATION. NEXPLANON® Etonogestrel extended release subdermal implant . Extended release implant, 68 mg per implant (to deliver up to 70 mcg etonogestrel per day),PRODUCT MONOGRAPH
VARIVAX® III (varicella virus vaccine, live, attenuated ) Page 6 of 24 Nursing Women: It is not known whether varicella vaccine virus is secreted in human milk. Therefore, because some viruses are secreted in human milk, caution should be exercised if VARIVAX® III is administered to a nursing woman.PRHADLIMA PUSHTOUCH
PrHADLIMA® PrHADLIMA® PushTouch® Page 1 of 148. PRODUCT MONOGRAPH . INCLUDING PATIENT MEDICATION INFORMATION . PrHADLIMA®. adalimumab injection . 40 mg in 0.8 mL sterile solution (50 mg/mL), pre-filled syringe for subcutaneous injectionPRODUCT MONOGRAPH
ESTROGEL® (17ß-estradiol, as estradiol hemihydrate) Product Monograph Page 5 of 39 for short-interval follow-up, a suspicious abnormality, or highly suggestive of malignancy) was significantly higher in the estrogen plus progestin group versus the placebo group.PRODUCT MONOGRAPH
GARDASIL®9 Page
4 of 45 INDICATIONS AND CLINICAL USE Girls and Women GARDASIL®9 is a vaccine indicated in girls and women 9 through 45 years of age for the prevention of infection caused by the Human Papillomavirus (HPV) types6,
PRODUCT MONOGRAPH
Cotazym® (Pancrelipase) Page 1 of 14 PRODUCT MONOGRAPH COTAZYM® Pancrelipase Preparations Cotazym® Capsules: 10,000 USP units (Lipase activity) / 40,000 USPKEYTRUDA® - MERCK
KEYTRUDA® (pembrolizumab) Page 4 of 161 RECENT MAJOR LABEL CHANGES 1 Indications 03/2021 4 Dosage and Administration, 4.2 Recommended Dose and Dosage Adjustment 04/2021 7 Warnings and Precautions 02/2021 HOME | MERCK CANADACONTACT USPRESCRIPTION PRODUCTSAPPLY NOWWORLDWIDEABOUT USNEWSROOM HADLIMA ® (adalimumab injection) Now Available for the Treatment of Rheumatoid Arthritis, Polyarticular Juvenile Idiopathic Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Adult Crohn’s Disease, Ulcerative Colitis, Hidradenitis Suppurativa, Plaque Psoriasis, Adult and Pediatric Uveitiss and men 9 - 45 years of age. Learn more. [PRODUCT MONOGRAPH TEMPLATE M-M-R® II (measles, mumps and rubella virus vaccine, live, attenuated, Merck Std.) Page 1 of 29. PRODUCT MONOGRAPH. M-M-R® II (measles, mumps and rubella virus vaccine, live, attenuated, Merck Std.) Single-dose vials . Lyophilized powder for injectionPROQUAD - MERCK
ProQuad® (Measles, Mumps, Rubella and Varicella Virus Vaccine Live) Page 6 of 42 Vaccine recipients should attempt to avoid, whenever possible, close association with high-risk individuals susceptible to varicella for up to 6 weeks following vaccination. PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION … NEXPLANON® (etonogestrel extended release subdermal implant) Page 1 of 56. PRODUCT MONOGRAPH . INCLUDING PATIENT MEDICATION INFORMATION. NEXPLANON® Etonogestrel extended release subdermal implant . Extended release implant, 68 mg per implant (to deliver up to 70 mcg etonogestrel per day),PRODUCT MONOGRAPH
VARIVAX® III (varicella virus vaccine, live, attenuated ) Page 6 of 24 Nursing Women: It is not known whether varicella vaccine virus is secreted in human milk. Therefore, because some viruses are secreted in human milk, caution should be exercised if VARIVAX® III is administered to a nursing woman.PRHADLIMA PUSHTOUCH
PrHADLIMA® PrHADLIMA® PushTouch® Page 1 of 148. PRODUCT MONOGRAPH . INCLUDING PATIENT MEDICATION INFORMATION . PrHADLIMA®. adalimumab injection . 40 mg in 0.8 mL sterile solution (50 mg/mL), pre-filled syringe for subcutaneous injectionPRODUCT MONOGRAPH
ESTROGEL® (17ß-estradiol, as estradiol hemihydrate) Product Monograph Page 5 of 39 for short-interval follow-up, a suspicious abnormality, or highly suggestive of malignancy) was significantly higher in the estrogen plus progestin group versus the placebo group.PRODUCT MONOGRAPH
GARDASIL®9 Page
4 of 45 INDICATIONS AND CLINICAL USE Girls and Women GARDASIL®9 is a vaccine indicated in girls and women 9 through 45 years of age for the prevention of infection caused by the Human Papillomavirus (HPV) types6,
PRODUCT MONOGRAPH
Cotazym® (Pancrelipase) Page 1 of 14 PRODUCT MONOGRAPH COTAZYM® Pancrelipase Preparations Cotazym® Capsules: 10,000 USP units (Lipase activity) / 40,000 USPKEYTRUDA® - MERCK
KEYTRUDA® (pembrolizumab) Page 4 of 161 RECENT MAJOR LABEL CHANGES 1 Indications 03/2021 4 Dosage and Administration, 4.2 Recommended Dose and Dosage Adjustment 04/2021 7 Warnings and Precautions 02/2021 CONTACT US | MERCK CANADA To get in touch with a Merck Canada employee, contact our Canadian head office. Here is how you can reach us: Merck Canada Inc. 16750 Trans-Canada Highway. Kirkland, Quebec H9H 4M7. Phone: 514-428-7920. Toll free phone: 1-800-361-7031. For more information about charitable contributions/donations support or to submit a request, please clickhere.
CAREERS | MERCK CANADA Apply Now. Learn more about our work, search for jobs, and gain the information you need to decide if Merck is a match for you. We'll show you where your expertise can add value and how to apply for the positions that interest you. In the end, we hope you discover morePRODUCT MONOGRAPH
ESTROGEL® (17ß-estradiol, as estradiol hemihydrate) Product Monograph Page 5 of 39 for short-interval follow-up, a suspicious abnormality, or highly suggestive of malignancy) was significantly higher in the estrogen plus progestin group versus the placebo group.PRODUCT MONOGRAPH
PRODUCT MONOGRAPH . PUREGON® (follitropin beta) Solution for injection in cartridges (recFSH) 300 IU/0.36 mL, 600 IU/0.72 mL or . 900 IU/1.08 mL solution for injectionPRODUCT MONOGRAPH
Page 1 of 34 PRODUCT MONOGRAPH PROMETRIUM® Progesterone capsules 100 mg Progestin Merck Canada Inc. 16750 route Transcanadienne Kirkland QCCanada H9H 4M7
PRODUCT MONOGRAPH
CANCIDAS® (caspofungin acetate) Page 6 of 50 Nursing Women: It is not known whether caspofungin is excreted in human milk. Caspofungin has been found in the milk of lactating laboratory animals. Women receiving CANCIDAS® should not breast-feed. Pediatrics (≤ 17 years of age): The safety and effectiveness of CANCIDAS® in pediatric patients aged 12 months to 17 years of age are supported byPRODUCT MONOGRAPH
FOSAMAX® (alendronate sodium) Page 1 of 42 PRODUCT MONOGRAPH FOSAMAX alendronate sodium tablets 70 mg alendronate Bone Metabolism Regulator Merck Canada Inc. Date of Revision: 16750 route Transcanadienne May 26, 2017 Kirkland, Quebec H9H 4M7KEYTRUDA - MERCK
KEYTRUDA® (pembrolizumab) Page 3 of 87 This product has been approved under the Notice of Compliance with Conditions (NOC/c) policy for one or all of its indicated uses. What is a Notice of Compliance withConditions (NOC/c)?
GARDASIL PRODUCT MONOGRAPH GARDASIL® Page 4 of 62 GARDASIL® is indicated in girls and women 9- through 26 years of age for the prevention of: - Anal cancer caused by HPV types 16 and 18 - Anal intraepithelial neoplasia (AIN) grades 1, 2, and 3 caused by HPV types 6, 11, 16, (ADALIMUMAB INJECTION) NOW AVAILABLE FOR THE TREATMENT OF same rigorous standards used to ensure the quality, efficacy and safety as in any other biologic drug.19 Biosimilars provide patients more treatment options to help manage their disease and symptoms. Clinical efficacy and safety studies have been conducted in patients with RA to demonstrate HOME | MERCK CANADACONTACT USPRESCRIPTION PRODUCTSAPPLY NOWWORLDWIDEABOUT USNEWSROOM HADLIMA ® (adalimumab injection) Now Available for the Treatment of Rheumatoid Arthritis, Polyarticular Juvenile Idiopathic Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Adult Crohn’s Disease, Ulcerative Colitis, Hidradenitis Suppurativa, Plaque Psoriasis, Adult and Pediatric Uveitiss and men 9 - 45 years of age. Learn more. [PRODUCT MONOGRAPH TEMPLATE M-M-R® II (measles, mumps and rubella virus vaccine, live, attenuated, Merck Std.) Page 1 of 29. PRODUCT MONOGRAPH. M-M-R® II (measles, mumps and rubella virus vaccine, live, attenuated, Merck Std.) Single-dose vials . Lyophilized powder for injectionPRHADLIMA PUSHTOUCH
PrHADLIMA® PrHADLIMA® PushTouch® Page 1 of 148. PRODUCT MONOGRAPH . INCLUDING PATIENT MEDICATION INFORMATION . PrHADLIMA®. adalimumab injection . 40 mg in 0.8 mL sterile solution (50 mg/mL), pre-filled syringe for subcutaneous injectionPROQUAD - MERCK
ProQuad® (Measles, Mumps, Rubella and Varicella Virus Vaccine Live) Page 6 of 42 Vaccine recipients should attempt to avoid, whenever possible, close association with high-risk individuals susceptible to varicella for up to 6 weeks following vaccination.PRODUCT MONOGRAPH
GARDASIL®9 Page
4 of 45 INDICATIONS AND CLINICAL USE Girls and Women GARDASIL®9 is a vaccine indicated in girls and women 9 through 45 years of age for the prevention of infection caused by the Human Papillomavirus (HPV) types6,
PRODUCT MONOGRAPH
VARIVAX® III (varicella virus vaccine, live, attenuated ) Page 6 of 24 Nursing Women: It is not known whether varicella vaccine virus is secreted in human milk. Therefore, because some viruses are secreted in human milk, caution should be exercised if VARIVAX® III is administered to a nursing woman.KEYTRUDA - MERCK
KEYTRUDA® (pembrolizumab) Page 3 of 87 This product has been approved under the Notice of Compliance with Conditions (NOC/c) policy for one or all of its indicated uses. What is a Notice of Compliance withConditions (NOC/c)?
GARDASIL PRODUCT MONOGRAPH GARDASIL® Page 1 of 62. PRODUCT MONOGRAPH. GARDASIL® Suspension for injection . Active Immunizing AgentPRODUCT MONOGRAPH
Cotazym® (Pancrelipase) Page 1 of 14 PRODUCT MONOGRAPH COTAZYM® Pancrelipase Preparations Cotazym® Capsules: 10,000 USP units (Lipase activity) / 40,000 USP (ADALIMUMAB INJECTION) NOW AVAILABLE FOR THE TREATMENT OF same rigorous standards used to ensure the quality, efficacy and safety as in any other biologic drug.19 Biosimilars provide patients more treatment options to help manage their disease and symptoms. Clinical efficacy and safety studies have been conducted in patients with RA to demonstrate HOME | MERCK CANADACONTACT USPRESCRIPTION PRODUCTSAPPLY NOWWORLDWIDEABOUT USNEWSROOM HADLIMA ® (adalimumab injection) Now Available for the Treatment of Rheumatoid Arthritis, Polyarticular Juvenile Idiopathic Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Adult Crohn’s Disease, Ulcerative Colitis, Hidradenitis Suppurativa, Plaque Psoriasis, Adult and Pediatric Uveitiss and men 9 - 45 years of age. Learn more. [PRODUCT MONOGRAPH TEMPLATE M-M-R® II (measles, mumps and rubella virus vaccine, live, attenuated, Merck Std.) Page 1 of 29. PRODUCT MONOGRAPH. M-M-R® II (measles, mumps and rubella virus vaccine, live, attenuated, Merck Std.) Single-dose vials . Lyophilized powder for injectionPRHADLIMA PUSHTOUCH
PrHADLIMA® PrHADLIMA® PushTouch® Page 1 of 148. PRODUCT MONOGRAPH . INCLUDING PATIENT MEDICATION INFORMATION . PrHADLIMA®. adalimumab injection . 40 mg in 0.8 mL sterile solution (50 mg/mL), pre-filled syringe for subcutaneous injectionPROQUAD - MERCK
ProQuad® (Measles, Mumps, Rubella and Varicella Virus Vaccine Live) Page 6 of 42 Vaccine recipients should attempt to avoid, whenever possible, close association with high-risk individuals susceptible to varicella for up to 6 weeks following vaccination.PRODUCT MONOGRAPH
GARDASIL®9 Page
4 of 45 INDICATIONS AND CLINICAL USE Girls and Women GARDASIL®9 is a vaccine indicated in girls and women 9 through 45 years of age for the prevention of infection caused by the Human Papillomavirus (HPV) types6,
PRODUCT MONOGRAPH
VARIVAX® III (varicella virus vaccine, live, attenuated ) Page 6 of 24 Nursing Women: It is not known whether varicella vaccine virus is secreted in human milk. Therefore, because some viruses are secreted in human milk, caution should be exercised if VARIVAX® III is administered to a nursing woman.KEYTRUDA - MERCK
KEYTRUDA® (pembrolizumab) Page 3 of 87 This product has been approved under the Notice of Compliance with Conditions (NOC/c) policy for one or all of its indicated uses. What is a Notice of Compliance withConditions (NOC/c)?
GARDASIL PRODUCT MONOGRAPH GARDASIL® Page 1 of 62. PRODUCT MONOGRAPH. GARDASIL® Suspension for injection . Active Immunizing AgentPRODUCT MONOGRAPH
Cotazym® (Pancrelipase) Page 1 of 14 PRODUCT MONOGRAPH COTAZYM® Pancrelipase Preparations Cotazym® Capsules: 10,000 USP units (Lipase activity) / 40,000 USP (ADALIMUMAB INJECTION) NOW AVAILABLE FOR THE TREATMENT OF same rigorous standards used to ensure the quality, efficacy and safety as in any other biologic drug.19 Biosimilars provide patients more treatment options to help manage their disease and symptoms. Clinical efficacy and safety studies have been conducted in patients with RA to demonstrate CONTACT US | MERCK CANADA To get in touch with a Merck Canada employee, contact our Canadian head office. Here is how you can reach us: Merck Canada Inc. 16750 Trans-Canada Highway. Kirkland, Quebec H9H 4M7. Phone: 514-428-7920. Toll free phone: 1-800-361-7031. For more information about charitable contributions/donations support or to submit a request, please clickhere.
PRESCRIPTION PRODUCTS Used under license. The following documents, Product Monograph and Consumer Information, are currently under revision and should be available shortly. For any information on our products, you may also contact our Medical Information Centre at 514-428-8600 or 1-800-567-2594. Close. PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION … NEXPLANON® (etonogestrel extended release subdermal implant) Page 1 of 56. PRODUCT MONOGRAPH . INCLUDING PATIENT MEDICATION INFORMATION. NEXPLANON® Etonogestrel extended release subdermal implant . Extended release implant, 68 mg per implant (to deliver up to 70 mcg etonogestrel per day),PRODUCT MONOGRAPH
PRODUCT MONOGRAPH . PUREGON® (follitropin beta) Solution for injection in cartridges (recFSH) 300 IU/0.36 mL, 600 IU/0.72 mL or . 900 IU/1.08 mL solution for injectionKEYTRUDA® - MERCK
KEYTRUDA® (pembrolizumab) Page 4 of 161 RECENT MAJOR LABEL CHANGES 1 Indications 03/2021 4 Dosage and Administration, 4.2 Recommended Dose and Dosage Adjustment 04/2021 7 Warnings and Precautions 02/2021PRODUCT MONOGRAPH
Page 1 of 34 PRODUCT MONOGRAPH PROMETRIUM® Progesterone capsules 100 mg Progestin Merck Canada Inc. 16750 route Transcanadienne Kirkland QCCanada H9H 4M7
PRODUCT MONOGRAPH
FOSAMAX® (alendronate sodium) Page 1 of 42 PRODUCT MONOGRAPH FOSAMAX alendronate sodium tablets 70 mg alendronate Bone Metabolism Regulator Merck Canada Inc. Date of Revision: 16750 route Transcanadienne May 26, 2017 Kirkland, Quebec H9H 4M7PRODUCT MONOGRAPH
ESTROGEL® (17ß-estradiol, as estradiol hemihydrate) Product Monograph Page 5 of 39 for short-interval follow-up, a suspicious abnormality, or highly suggestive of malignancy) was significantly higher in the estrogen plus progestin group versus the placebo group. PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION www.merck.ca. Date of Initial Approval: September 5, 2018 . Date of Preparation : September 5 , 2018 . Submission Control No: 211000 (Internal Filing: March 13, 2020) IMPORTANT: PLEASE READ IMPORTANT: PLEASE READ ZENHALE® (mometasone furoate / formoterol fumarate dihydrate inhalation aerosol) Page 2 of 7 • have eye disorders such as glaucoma or cataracts • have hypoprothrombinemia a blood clotting problem( ) and are taking acetylsalicylic acid(aspirin)
HOME | MERCK CANADACONTACT USPRESCRIPTION PRODUCTSAPPLY NOWWORLDWIDEABOUT USNEWSROOM HADLIMA ® (adalimumab injection) Now Available for the Treatment of Rheumatoid Arthritis, Polyarticular Juvenile Idiopathic Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Adult Crohn’s Disease, Ulcerative Colitis, Hidradenitis Suppurativa, Plaque Psoriasis, Adult and Pediatric Uveitiss and men 9 - 45 years of age. Learn more.PRODUCT MONOGRAPH
VARIVAX® III (varicella virus vaccine, live, attenuated ) Page 6 of 24 Nursing Women: It is not known whether varicella vaccine virus is secreted in human milk. Therefore, because some viruses are secreted in human milk, caution should be exercised if VARIVAX® III is administered to a nursing woman. PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION … NEXPLANON® (etonogestrel extended release subdermal implant) Page 1 of 56. PRODUCT MONOGRAPH . INCLUDING PATIENT MEDICATION INFORMATION. NEXPLANON® Etonogestrel extended release subdermal implant . Extended release implant, 68 mg per implant (to deliver up to 70 mcg etonogestrel per day),PRODUCT MONOGRAPH
ANDRIOL® (testosterone undecanoate capsules) Page 1 of 27 PRODUCT MONOGRAPH ANDRIOL® (testosterone undecanoate capsules) 40 mg Androgen Merck Canada Inc. 16750 route Transcanadienne Kirkland, QC Canada H9H4M7
PRHADLIMA PUSHTOUCH
PrHADLIMA® PrHADLIMA® PushTouch® Page 1 of 148. PRODUCT MONOGRAPH . INCLUDING PATIENT MEDICATION INFORMATION . PrHADLIMA®. adalimumab injection . 40 mg in 0.8 mL sterile solution (50 mg/mL), pre-filled syringe for subcutaneous injectionPRODUCT MONOGRAPH
GARDASIL®9 Page
4 of 45 INDICATIONS AND CLINICAL USE Girls and Women GARDASIL®9 is a vaccine indicated in girls and women 9 through 45 years of age for the prevention of infection caused by the Human Papillomavirus (HPV) types6,
PROQUAD - MERCK
ProQuad® (Measles, Mumps, Rubella and Varicella Virus Vaccine Live) Page 6 of 42 Vaccine recipients should attempt to avoid, whenever possible, close association with high-risk individuals susceptible to varicella for up to 6 weeks following vaccination.KEYTRUDA® - MERCK
KEYTRUDA® (pembrolizumab) Page 4 of 161 RECENT MAJOR LABEL CHANGES 1 Indications 03/2021 4 Dosage and Administration, 4.2 Recommended Dose and Dosage Adjustment 04/2021 7 Warnings and Precautions 02/2021KEYTRUDA - MERCK
KEYTRUDA® (pembrolizumab) Page 3 of 87 This product has been approved under the Notice of Compliance with Conditions (NOC/c) policy for one or all of its indicated uses. What is a Notice of Compliance withConditions (NOC/c)?
GARDASIL PRODUCT MONOGRAPH GARDASIL® Page 4 of 62 GARDASIL® is indicated in girls and women 9- through 26 years of age for the prevention of: - Anal cancer caused by HPV types 16 and 18 - Anal intraepithelial neoplasia (AIN) grades 1, 2, and 3 caused by HPV types 6, 11, 16, HOME | MERCK CANADACONTACT USPRESCRIPTION PRODUCTSAPPLY NOWWORLDWIDEABOUT USNEWSROOM HADLIMA ® (adalimumab injection) Now Available for the Treatment of Rheumatoid Arthritis, Polyarticular Juvenile Idiopathic Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Adult Crohn’s Disease, Ulcerative Colitis, Hidradenitis Suppurativa, Plaque Psoriasis, Adult and Pediatric Uveitiss and men 9 - 45 years of age. Learn more.PRODUCT MONOGRAPH
VARIVAX® III (varicella virus vaccine, live, attenuated ) Page 6 of 24 Nursing Women: It is not known whether varicella vaccine virus is secreted in human milk. Therefore, because some viruses are secreted in human milk, caution should be exercised if VARIVAX® III is administered to a nursing woman. PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION … NEXPLANON® (etonogestrel extended release subdermal implant) Page 1 of 56. PRODUCT MONOGRAPH . INCLUDING PATIENT MEDICATION INFORMATION. NEXPLANON® Etonogestrel extended release subdermal implant . Extended release implant, 68 mg per implant (to deliver up to 70 mcg etonogestrel per day),PRODUCT MONOGRAPH
ANDRIOL® (testosterone undecanoate capsules) Page 1 of 27 PRODUCT MONOGRAPH ANDRIOL® (testosterone undecanoate capsules) 40 mg Androgen Merck Canada Inc. 16750 route Transcanadienne Kirkland, QC Canada H9H4M7
PRHADLIMA PUSHTOUCH
PrHADLIMA® PrHADLIMA® PushTouch® Page 1 of 148. PRODUCT MONOGRAPH . INCLUDING PATIENT MEDICATION INFORMATION . PrHADLIMA®. adalimumab injection . 40 mg in 0.8 mL sterile solution (50 mg/mL), pre-filled syringe for subcutaneous injectionPRODUCT MONOGRAPH
GARDASIL®9 Page
4 of 45 INDICATIONS AND CLINICAL USE Girls and Women GARDASIL®9 is a vaccine indicated in girls and women 9 through 45 years of age for the prevention of infection caused by the Human Papillomavirus (HPV) types6,
PROQUAD - MERCK
ProQuad® (Measles, Mumps, Rubella and Varicella Virus Vaccine Live) Page 6 of 42 Vaccine recipients should attempt to avoid, whenever possible, close association with high-risk individuals susceptible to varicella for up to 6 weeks following vaccination.KEYTRUDA® - MERCK
KEYTRUDA® (pembrolizumab) Page 4 of 161 RECENT MAJOR LABEL CHANGES 1 Indications 03/2021 4 Dosage and Administration, 4.2 Recommended Dose and Dosage Adjustment 04/2021 7 Warnings and Precautions 02/2021KEYTRUDA - MERCK
KEYTRUDA® (pembrolizumab) Page 3 of 87 This product has been approved under the Notice of Compliance with Conditions (NOC/c) policy for one or all of its indicated uses. What is a Notice of Compliance withConditions (NOC/c)?
GARDASIL PRODUCT MONOGRAPH GARDASIL® Page 4 of 62 GARDASIL® is indicated in girls and women 9- through 26 years of age for the prevention of: - Anal cancer caused by HPV types 16 and 18 - Anal intraepithelial neoplasia (AIN) grades 1, 2, and 3 caused by HPV types 6, 11, 16, VACCINES | MERCK CANADA Vaccines are one of the greatest public health success stories of the 20th century, and Merck has played its part in that story. We are one of a few companies who remain dedicated to the complex business of researching and producing vaccines. Our unique contributions include the prevention of now rare diseases, like measles and mumps, toCOMPANY STATEMENTS
Media Centre. For journalists with a media inquiry, please contact us: 1-833-90MERCK (1-833-906-3725).PROQUAD - MERCK
ProQuad® (Measles, Mumps, Rubella and Varicella Virus Vaccine Live) Page 6 of 42 Vaccine recipients should attempt to avoid, whenever possible, close association with high-risk individuals susceptible to varicella for up to 6 weeks following vaccination.PRODUCT MONOGRAPH
ANDRIOL® (testosterone undecanoate capsules) Page 1 of 27 PRODUCT MONOGRAPH ANDRIOL® (testosterone undecanoate capsules) 40 mg Androgen Merck Canada Inc. 16750 route Transcanadienne Kirkland, QC Canada H9H4M7
PRODUCT MONOGRAPH
not be given to patients in whom unrecognized coronary artery disease (CAD) is predicted by the presence of risk factors (e.g., hypertension, hypercholesterolemia, smoker, obesity, diabetes, strong family history of CAD, female withPRODUCT MONOGRAPH
CANCIDAS® (caspofungin acetate) Page 6 of 50 Nursing Women: It is not known whether caspofungin is excreted in human milk. Caspofungin has been found in the milk of lactating laboratory animals. Women receiving CANCIDAS® should not breast-feed. Pediatrics (≤ 17 years of age): The safety and effectiveness of CANCIDAS® in pediatric patients aged 12 months to 17 years of age are supported byPRODUCT MONOGRAPH
PRODUCT MONOGRAPH . PUREGON® (follitropin beta) Solution for injection in cartridges (recFSH) 300 IU/0.36 mL, 600 IU/0.72 mL or . 900 IU/1.08 mL solution for injectionNEWS RELEASE
- 3 - About Colorectal Cancer Colorectal cancer occurs when the cells lining the rectum or colon become abnormal and begin to divide rapidly, resulting in the development of benign tumours.14 Over time, the DNA of the benign tumours can change, causing the tumours to become cancerous.15 This can result in the cancer spreading to the blood and lymph vessels, further allowing it to metastasizePRODUCT MONOGRAPH
Cotazym® (Pancrelipase) Page 1 of 14 PRODUCT MONOGRAPH COTAZYM® Pancrelipase Preparations Cotazym® Capsules: 10,000 USP units (Lipase activity) / 40,000 USP (ADALIMUMAB INJECTION) NOW AVAILABLE FOR THE TREATMENT OF same rigorous standards used to ensure the quality, efficacy and safety as in any other biologic drug.19 Biosimilars provide patients more treatment options to help manage their disease and symptoms. Clinical efficacy and safety studies have been conducted in patients with RA to demonstrate HOME | MERCK CANADACONTACT USPRESCRIPTION PRODUCTSAPPLY NOWWORLDWIDEABOUT USNEWSROOM HADLIMA ® (adalimumab injection) Now Available for the Treatment of Rheumatoid Arthritis, Polyarticular Juvenile Idiopathic Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Adult Crohn’s Disease, Ulcerative Colitis, Hidradenitis Suppurativa, Plaque Psoriasis, Adult and Pediatric Uveitiss and men 9 - 45 years of age. Learn more. CONTACT US | MERCK CANADA To get in touch with a Merck Canada employee, contact our Canadian head office. Here is how you can reach us: Merck Canada Inc. 16750 Trans-Canada Highway. Kirkland, Quebec H9H 4M7. Phone: 514-428-7920. Toll free phone: 1-800-361-7031. For more information about charitable contributions/donations support or to submit a request, please clickhere.
PRESCRIPTION PRODUCTS Used under license. The following documents, Product Monograph and Consumer Information, are currently under revision and should be available shortly. For any information on our products, you may also contact our Medical Information Centre at 514-428-8600 or 1-800-567-2594. Close. VACCINES | MERCK CANADA Vaccines are one of the greatest public health success stories of the 20th century, and Merck has played its part in that story. We are one of a few companies who remain dedicated to the complex business of researching and producing vaccines. Our unique contributions include the prevention of now rare diseases, like measles and mumps, toPRODUCT MONOGRAPH
VARIVAX® III (varicella virus vaccine, live, attenuated ) Page 6 of 24 Nursing Women: It is not known whether varicella vaccine virus is secreted in human milk. Therefore, because some viruses are secreted in human milk, caution should be exercised if VARIVAX® III is administered to a nursing woman.KEYTRUDA® - MERCK
KEYTRUDA® (pembrolizumab) Page 4 of 161 RECENT MAJOR LABEL CHANGES 1 Indications 03/2021 4 Dosage and Administration, 4.2 Recommended Dose and Dosage Adjustment 04/2021 7 Warnings and Precautions 02/2021PROQUAD - MERCK
ProQuad® (Measles, Mumps, Rubella and Varicella Virus Vaccine Live) Page 6 of 42 Vaccine recipients should attempt to avoid, whenever possible, close association with high-risk individuals susceptible to varicella for up to 6 weeks following vaccination. GARDASIL PRODUCT MONOGRAPH GARDASIL® Page 1 of 62. PRODUCT MONOGRAPH. GARDASIL® Suspension for injection . Active Immunizing AgentPRODUCT MONOGRAPH
GARDASIL®9 Page
4 of 45 INDICATIONS AND CLINICAL USE Girls and Women GARDASIL®9 is a vaccine indicated in girls and women 9 through 45 years of age for the prevention of infection caused by the Human Papillomavirus (HPV) types6,
PRODUCT MONOGRAPH
Cotazym® (Pancrelipase) Page 1 of 14 PRODUCT MONOGRAPH COTAZYM® Pancrelipase Preparations Cotazym® Capsules: 10,000 USP units (Lipase activity) / 40,000 USP HOME | MERCK CANADACONTACT USPRESCRIPTION PRODUCTSAPPLY NOWWORLDWIDEABOUT USNEWSROOM HADLIMA ® (adalimumab injection) Now Available for the Treatment of Rheumatoid Arthritis, Polyarticular Juvenile Idiopathic Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Adult Crohn’s Disease, Ulcerative Colitis, Hidradenitis Suppurativa, Plaque Psoriasis, Adult and Pediatric Uveitiss and men 9 - 45 years of age. Learn more. CONTACT US | MERCK CANADA To get in touch with a Merck Canada employee, contact our Canadian head office. Here is how you can reach us: Merck Canada Inc. 16750 Trans-Canada Highway. Kirkland, Quebec H9H 4M7. Phone: 514-428-7920. Toll free phone: 1-800-361-7031. For more information about charitable contributions/donations support or to submit a request, please clickhere.
PRESCRIPTION PRODUCTS Used under license. The following documents, Product Monograph and Consumer Information, are currently under revision and should be available shortly. For any information on our products, you may also contact our Medical Information Centre at 514-428-8600 or 1-800-567-2594. Close. VACCINES | MERCK CANADA Vaccines are one of the greatest public health success stories of the 20th century, and Merck has played its part in that story. We are one of a few companies who remain dedicated to the complex business of researching and producing vaccines. Our unique contributions include the prevention of now rare diseases, like measles and mumps, toPRODUCT MONOGRAPH
VARIVAX® III (varicella virus vaccine, live, attenuated ) Page 6 of 24 Nursing Women: It is not known whether varicella vaccine virus is secreted in human milk. Therefore, because some viruses are secreted in human milk, caution should be exercised if VARIVAX® III is administered to a nursing woman.KEYTRUDA® - MERCK
KEYTRUDA® (pembrolizumab) Page 4 of 161 RECENT MAJOR LABEL CHANGES 1 Indications 03/2021 4 Dosage and Administration, 4.2 Recommended Dose and Dosage Adjustment 04/2021 7 Warnings and Precautions 02/2021PROQUAD - MERCK
ProQuad® (Measles, Mumps, Rubella and Varicella Virus Vaccine Live) Page 6 of 42 Vaccine recipients should attempt to avoid, whenever possible, close association with high-risk individuals susceptible to varicella for up to 6 weeks following vaccination. GARDASIL PRODUCT MONOGRAPH GARDASIL® Page 1 of 62. PRODUCT MONOGRAPH. GARDASIL® Suspension for injection . Active Immunizing AgentPRODUCT MONOGRAPH
GARDASIL®9 Page
4 of 45 INDICATIONS AND CLINICAL USE Girls and Women GARDASIL®9 is a vaccine indicated in girls and women 9 through 45 years of age for the prevention of infection caused by the Human Papillomavirus (HPV) types6,
PRODUCT MONOGRAPH
Cotazym® (Pancrelipase) Page 1 of 14 PRODUCT MONOGRAPH COTAZYM® Pancrelipase Preparations Cotazym® Capsules: 10,000 USP units (Lipase activity) / 40,000 USP CONTACT US | MERCK CANADA To get in touch with a Merck Canada employee, contact our Canadian head office. Here is how you can reach us: Merck Canada Inc. 16750 Trans-Canada Highway. Kirkland, Quebec H9H 4M7. Phone: 514-428-7920. Toll free phone: 1-800-361-7031. For more information about charitable contributions/donations support or to submit a request, please clickhere.
PRESCRIPTION PRODUCTS Used under license. The following documents, Product Monograph and Consumer Information, are currently under revision and should be available shortly. For any information on our products, you may also contact our Medical Information Centre at 514-428-8600 or 1-800-567-2594. Close.PRODUCT MONOGRAPH
ANDRIOL® (testosterone undecanoate capsules) Page 1 of 27 PRODUCT MONOGRAPH ANDRIOL® (testosterone undecanoate capsules) 40 mg Androgen Merck Canada Inc. 16750 route Transcanadienne Kirkland, QC Canada H9H4M7
PRODUCT MONOGRAPH
CANCIDAS® (caspofungin acetate) Page 6 of 50 Nursing Women: It is not known whether caspofungin is excreted in human milk. Caspofungin has been found in the milk of lactating laboratory animals. Women receiving CANCIDAS® should not breast-feed. Pediatrics (≤ 17 years of age): The safety and effectiveness of CANCIDAS® in pediatric patients aged 12 months to 17 years of age are supported byPRODUCT MONOGRAPH
PRODUCT MONOGRAPH . PUREGON® (follitropin beta) Solution for injection in cartridges (recFSH) 300 IU/0.36 mL, 600 IU/0.72 mL or . 900 IU/1.08 mL solution for injectionPRODUCT MONOGRAPH
ESTROGEL® (17ß-estradiol, as estradiol hemihydrate) Product Monograph Page 5 of 39 for short-interval follow-up, a suspicious abnormality, or highly suggestive of malignancy) was significantly higher in the estrogen plus progestin group versus the placebo group. [PRODUCT MONOGRAPH TEMPLATE Kirkland, QC Canada H9H 4M7 . www.organon.ca . Date of Revision: April 23, 2021 : Submission Control No: 239493KEYTRUDA - MERCK
KEYTRUDA® (pembrolizumab) Page 3 of 87 This product has been approved under the Notice of Compliance with Conditions (NOC/c) policy for one or all of its indicated uses. What is a Notice of Compliance withConditions (NOC/c)?
PR RENFLEXISTM
RENFLEXIS. TM. Page 4 of 115. PR . RENFLEXIS. TM . Infliximab for Injection. RENFLEXISTM (Infliximab for Injection) is a biosimilar biologic drug (biosimilar) to Remicade®. PART I: HEALTH PROFESSIONAL INFORMATION 1 INDICATIONS Indications have been granted on the basis of similarity between IMPORTANT: PLEASE READ IMPORTANT: PLEASE READ ZENHALE® (mometasone furoate / formoterol fumarate dihydrate inhalation aerosol) Page 2 of 7 • have eye disorders such as glaucoma or cataracts • have hypoprothrombinemia a blood clotting problem( ) and are taking acetylsalicylic acid(aspirin)
<iframe
src="https://www.googletagmanager.com/ns.html?id=GTM-M49QW5N" height="0" width="0" style="display:none;visibility:hidden"/>menu Menu
* WORLDWIDE
* CONTACT US
* English Français
* About Us
_close_
* About Us
* Corporate Responsibility * Contributions and Donations* Leadership
* Featured Stories
* Products
_close_
* Vaccines
* Prescription Products* Animal Health
* Newsroom
_close_
* Latest News
* Corporate News
* Product News
* Company Statements* Social Media
* Careers
* English Français
* About Us _navigate_next_* About Us
* Corporate Responsibility* Leadership
* Featured Stories
* Product _navigate_next_* Vaccines
* Prescription Products* Animal Health
* Newsroom _navigate_next_* Latest News
* Corporate News
* Product News
* Company Statements* Social Media
* Careers _navigate_next_* Contact Us
Merck's Commitment to Antimicrobial InnovationLearn more
Health Canada Approves KEYTRUDA® (pembrolizumab) as First-line Treatment for Patients with Metastatic or Unresectable Recurrent Head and Neck Squamous Cell CarcinomaLearn more
NEXPLANON®️ Contraceptive Arm Implant Now Available for Use inCanada
Learn more
Health Canada Approves KEYTRUDA® (pembrolizumab) as First-line Treatment for Patients with Metastatic or Unresectable Recurrent Head and Neck Squamous Cell CarcinomaLearn more
NEXPLANON®️ Contraceptive Arm Implant Now Available for Use inCanada
Learn more
BRENZYS®️ (etanercept injection) now indicated for the Treatment of Plaque Psoriasis, Psoriatic Arthritis and Juvenile IdiopathicArthritis
Learn more
Merck's HPV Vaccine, GARDASIL®️9, now indicated in boys and men 9 -45 years of age
Learn more
How We Are RespondingLearn more
Merck announces three significant scientific efforts in the fightagainst COVID-19
Learn more
Merck Canada stands alongside Innovative Medicines Canada and other company members in the campaign to help frontline-healthcare workers fight against COVID-19. Link to IMC Press Release Link to Merck Connect Press Release ARE YOU A HEALTHCARE PROFESSIONAL WITH QUESTIONS OR COMMENTS ABOUT OURPRODUCTS?
Submit a
Medical
Inquiry
Report an
Adverse
Event
Report a
Product
Complaint
Submit
General
Feedback
Submit a
Product Stability
Request
Submit a MEDICAL INQUIRY Report an ADVERSE EVENT Report a PRODUCT COMPLAINT Submit GENERAL FEEDBACK Submit a PRODUCT STABILITY REQUEST AskMerck.ca can help you find what you need.Visit AskMerck.ca
Merck Biosimilar is at your side at every step.Learn more
We have always been and always will be inventing, and we do it for the single greatest purpose: life.Learn more
LATEST NEWS
CONNECT WITH US ON SOCIALOTHER MERCK SITES
Merck Canada Update on COVID-19April 6, 2020
Merck Canada stands alongside Innovative Medicines Canada and other company members in the campaign to help frontline-healthcare workers fight against COVID-19April 3, 2020
Merck Canada Statement on COVID-19Mar 13, 2020
Health Canada Approves KEYTRUDA®️ (pembrolizumab) as First-Line Treatment for Patients with Advanced Renal Cell Carcinoma (RCC)Jan 23, 2020
Ontario and Quebec provide reimbursement for HIV therapies PIFELTRO®️ (doravirine) and DELSTRIGO®️ (doravirine/lamivudine/tenofovir disoproxil fumarate)Nov 18, 2019
SEE ALL LATEST NEWS
*
*
*
*
*
OTHER MERCK SITES
Merck Patients First Awards*
Merck for Mothers
*
Merck Manuals
*
Merck.com
*
Investors
Copyright © 2018 Merck Canada Inc. All rights reserved.* Privacy
* Terms of use
Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. * Social media guidelines * Terms and conditions for sales You are now leaving the Merck.ca site, a website maintained by MerckCanada Inc.
The link is provided for your convenience only. Merck Canada Inc. takes no responsibility for the content of any website maintained by any third party and makes no representation as to the accuracy or completeness of any information available through this or anysubsequent link.
OK Cancel
Forward-Looking Statement × Forward-Looking Statement of MSD & Co., Inc., Kenilworth, NJ, USA This website of MSD & Co., Inc., Kenilworth, NJ, USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline products that the products will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-lookingstatements.
Risks and uncertainties include, but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and healthcare legislation in the United States and internationally; global trends toward healthcare cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions. The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2015 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov).No Duty to Update
The information contained in this website was current as of the date presented. The company assumes no duty to update the information to reflect subsequent developments. Consequently, the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after thepresentation date.
Details
Copyright © 2024 ArchiveBay.com. All rights reserved. Terms of Use | Privacy Policy | DMCA | 2021 | Feedback | Advertising | RSS 2.0